Litigation Details for ROXANE LABORATORIES, INC. v. NOVEL LABORATORIES, INC. (D.N.J. 2015)
✉ Email this page to a colleague
ROXANE LABORATORIES, INC. v. NOVEL LABORATORIES, INC. (D.N.J. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-07-17 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-09-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Patents | 6,576,665 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ROXANE LABORATORIES, INC. v. NOVEL LABORATORIES, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for ROXANE LABORATORIES, INC. v. NOVEL LABORATORIES, INC. (D.N.J. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-07-17 | 1 | certification stating that at least United States Patent No. 6,576,665, which is listed in the Orange … infringement of United States Patent No. 8,563,032 (“the ’032 Patent”), arising from Novel’s submission… THE PATENT-IN-SUIT 9. On October 22, 2013, the United States Patent and Trademark…the ’032 Patent is attached hereto as Exhibit A. Roxane is the record owner of the ’032 Patent by assignment… likely would infringe Roxane’s ’032 Patent since the ’032 Patent issued on October 22, 2013. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
